Skip to content
GERICLINICS

Flashcards · Module 15

🦴 Bones, Joints & Vessels (Rheumatology & Bone Health)

4 of 4 cards published · read by the site’s author on 17 November 2026

Osteoporosis & FRAX: When to treat WITHOUT waiting for a DEXA scan

Needs clinical review

The Big Misconception:

Many students believe you can only diagnose and treat osteoporosis if a DEXA scan shows a T-score ≤ -2.5. That is false!

The 3 Absolute Indications to Start Anti-Resorptive Therapy:

  1. 💥 ANY Fragility Fracture: A fracture occurring from standing height or less (hip, vertebral compression, wrist, humerus) in an older adult EQUALS OSTEOPOROSIS, regardless of what the DEXA score says!

  2. 📉 DEXA T-score ≤ -2.5 at the femoral neck, total hip, or lumbar spine.

  3. ⚖️ Osteopenia (T-score -1.0 to -2.5) PLUS elevated FRAX Score:

    • 10-year probability of Hip Fracture ≥ 3%, OR

    • 10-year probability of Major Osteoporotic Fracture ≥ 20%

FRAX Risk Factors:

Age, sex, BMI, previous fracture, parental hip fracture, current smoking, glucocorticoids (≥5 mg prednisone for >3 months), rheumatoid arthritis, secondary osteoporosis, and alcohol (≥3 units/day).

One-Liner: Treat osteoporosis if there is any fragility fracture, a T-score ≤ -2.5, or osteopenia with a FRAX score ≥3% for hip or ≥20% for major fracture.
Sources checked (1) · 15 November 2026

Bisphosphonate "Drug Holiday" vs. Denosumab Rebound Disaster

Needs clinical review

A Tale of Two Bone Drugs:

1. Bisphosphonates (Alendronate, Risedronate, Zoledronic Acid):

  • How they work: Chemically bind to hydroxyapatite crystals in the bone mineral matrix. They stay locked in the skeleton for years!

  • Why take a "Drug Holiday": long-term therapy brings rare but serious adverse events: atypical femoral fractures (AFF) and osteonecrosis of the jaw (ONJ).

  • The Protocol: in selected lower-risk patients, pause therapy; because the drug is retained in bone, its effect can persist after stopping.

2. Denosumab (Prolia - RANKL Monoclonal Antibody):

  • How it works: a monoclonal antibody against RANKL.

  • The Disaster of Stopping: stopping denosumab can cause rebound high bone turnover, rapid bone loss and multiple vertebral fractures.

  • Bone turnover skyrockets, leading to rapid bone loss and a cluster of multiple spontaneous vertebral compression fractures!

  • 🚨 WARD RULE: Don't stop denosumab without a plan: follow it with a bisphosphonate ("exit" therapy) to prevent rebound bone loss and vertebral fractures.

One-Liner: Bisphosphonates are retained in bone, so selected lower-risk patients can take a drug holiday; stopping denosumab can trigger rebound bone loss and multiple vertebral fractures unless a bisphosphonate follows.
Sources checked (1) · 15 November 2026

Polymyalgia Rheumatica (PMR) vs. Giant Cell Arteritis (GCA)

Needs clinical review

The Clinical Twins:

PMR and GCA are closely related inflammatory disorders, often seen as one disease spectrum. About 22% of people with PMR have GCA at diagnosis; about half of people with GCA have PMR.

Comparison Table:

FeaturePolymyalgia Rheumatica (PMR) 🦺Giant Cell Arteritis (GCA) 👓
SymptomsAching and morning stiffness in the neck, shoulder and hip girdles (>45 min in the classification criteria), usually after age 50• New localized temporal headache
• Scalp tenderness (brushing hair hurts)
• Jaw claudication (pain while chewing)
• Visual changes (amaurosis fugax)
Emergency?No — debilitating, but not blinding🚨 YES — Ophthalmic Emergency! Irreversible blindness from ischemic optic neuropathy
Lab FindingsRaised ESR and CRP, normal CK (not a myositis)Raised ESR and CRP (an ESR >50 mm/h is a classic criterion)
Steroid DoseLow-Dose Prednisone: 12.5 to 25 mg/day (quick improvement is typical; its absence suggests another diagnosis)High-Dose Prednisone: 40 to 60 mg/day (or IV Methylprednisolone 1000 mg/d if visual symptoms)
Biopsy?No biopsy neededTemporal Artery Biopsy (never delay steroids for biopsy!)
One-Liner: PMR causes shoulder/hip morning stiffness treated with low-dose steroids; GCA causes temporal headache and jaw claudication, risks blindness, and needs immediate high-dose steroids (40–60 mg).
Sources checked (3) · 15 November 2026

Note: An ESR above 50 mm/h is one of the 1990 ACR classification criteria for GCA. (Diagnosis and management of giant cell arteritis (2026))

Pseudogout (CPPD) vs. Gout: Rhomboids vs. Needles

Needs clinical review

The Classic Wards Scenario:

An 82-year-old in the hospital recovering from hip surgery or severe pneumonia suddenly develops an agonizing, hot, red, swollen knee. Is it gout or pseudogout?

The Crystal Showdown:

FeatureCPPD / Pseudogout 💎Gout 🪡
Crystal CompositionCalcium Pyrophosphate DihydrateMonosodium Urate
Polarized MicroscopyWeakly positively birefringent (or non-birefringent), rhomboid-shaped crystalsNegatively birefringent, needle-shaped crystals (turn YELLOW when parallel to slow axis)
Favorite JointKnee (most common), wrist, hips, pubic symphysis1st Metatarsophalangeal (MTP) joint (Podagra)
Provoking EventsMedical illness, surgery, trauma, hyperparathyroidism, hemochromatosisPurine-rich meals, alcohol, loop diuretics, dehydration
X-Ray FindingsChondrocalcinosis (linear calcification inside cartilage / knee menisci)"Punched-out" erosions (advanced disease only)

Treatment in Older Adults:

  • Avoid systemic NSAIDs (risks AKI and GI bleeds).

  • Prefer intra-articular steroid injection, low-dose Colchicine (adjust for renal function), or a short course of oral Prednisone.

One-Liner: Pseudogout = weakly positively birefringent rhomboid crystals, knee most often, chondrocalcinosis; Gout = negatively birefringent needle crystals, first MTP (podagra).
Sources checked (4) · 15 November 2026